Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCHP vs GSK✓SelectedUSD · GSKMCHP vs GSK performance historyLatest closeAs of-4.93%11/16
Stock and ETF performance explorer

MCHP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-22.4%
GSK return
+46.9%
Excess return
-69.3%
Maximum drawdown
-63.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.9%-0.1%-4.8%-4.9%
7D-4.7%-1.3%-3.3%-4.4%
30D-20.6%+2.7%-23.3%-21.1%
3M-25.5%+2.7%-28.2%-26.1%
6M-36.8%+3.3%-40.2%-37.8%
YTD-6.4%+6.5%-12.9%-9.0%
1Y+12.5%+10.7%+1.9%+8.3%
3Y-23.0%+64.4%-87.4%-34.8%
5Y-22.4%+46.7%-69.1%-38.8%
All-22.4%+46.9%-69.3%-38.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling